Related Experiment Video
Updated: Mar 27, 2026

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
Published on: May 11, 2020
Reframing veterinary vaccine quality control: Integrating alternative assays within lifecycle-based regulatory
1The Central Laboratory for Evaluation of Veterinary Biologics, Agricultural Research Center, P.O. Box 131, Cairo 11381, Egypt.
Abstract:
Veterinary vaccine quality assurance has traditionally relied on animal-based potency, safety, and efficacy tests, including challenge protection and in vivo titration assays. Although historically regarded as regulatory gold standards, these methods are increasingly constrained by ethical considerations, high costs, limited throughput, and prolonged timelines. In response, strong scientific and regulatory momentum now supports alternative approaches that reduce or replace animal use while maintaining confidence in vaccine performance. This review critically examines the current landscape of non-animal and reduced-animal methodologies for veterinary vaccine evaluation within the 3Rs framework (Replacement, Reduction, and Refinement). We synthesize advances across five methodological domains: molecular and genetic quantification (including qPCR, digital PCR, and DIVA strategies); cell-based and in vitro functional potency assays; immunochemical and point-of-care platforms; physicochemical and analytical characterization; and systems-level immunological and multi-omics approaches. For each category, we discuss scientific principles, analytical performance, validation requirements, and regulatory acceptance, with emphasis on alignment with WOAH and VICH guidance. Practical challenges related to assay standardization, reference materials, infrastructure, and inter-laboratory reproducibility are addressed. Species-specific case studies spanning livestock, companion animal, and poultry vaccines including foot-and-mouth disease, lumpy skin disease, rabies, and avian influenza illustrate how integrated, weight-of-evidence strategies support batch release, consistency testing, and post-licensure surveillance. Collectively, the evidence supports a paradigm shift toward data-rich, mechanism-informed quality-control frameworks that enhance efficiency, ethical compliance, and regulatory confidence in veterinary vaccine evaluation.
More Related Videos
07:43Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
Published on: July 14, 2023
09:57Development and Validation of a Quantitative PCR Method for Equid Herpesvirus-2 Diagnostics in Respiratory Fluids
Published on: March 17, 2016
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Vaccine Production
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Toxicity Testing in Animals
In Vitro Drug Release Testing: Overview, Development and Validation
Drug Regulation